Hematopoietic stem cells for treatment of non-Hodgkin's lymphoma

The aim of this study is to assess whether transplantation of CD34+ hematopoietic stem cells in combination with a specific regimen of chemotherapy, can improve the clinical outcome of patients suffering from mantle cell lymphoma and relapsed low-grade non-Hodgkin's lymphoma.